Mostra el registre parcial de l'element
dc.contributor.author | Francisco Javier Rodriguez-Jimenez | |
dc.contributor.author | Vilches, Angel | |
dc.contributor.author | Perez-Arago, Maria Amparo | |
dc.contributor.author | Clemente, Eleonora | |
dc.contributor.author | Roman, Raquel | |
dc.contributor.author | Leal, Juliette | |
dc.contributor.author | Artero Castro, Ana | |
dc.contributor.author | Fustero Lardiés, Santos | |
dc.contributor.author | Moreno-Manzano, Victoria | |
dc.contributor.author | Jendelova, Pavla | |
dc.contributor.author | Stojkovic, Miodrag | |
dc.contributor.author | Erceg, Slaven | |
dc.date.accessioned | 2022-05-10T14:30:32Z | |
dc.date.available | 2022-05-10T14:30:32Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Francisco Javier Rodriguez-Jimenez Vilches, Angel Perez-Arago, Maria Amparo Clemente, Eleonora Roman, Raquel Leal, Juliette Artero Castro, Ana Fustero Lardiés, Santos Moreno-Manzano, Victoria Jendelova, Pavla Stojkovic, Miodrag Erceg, Slaven 2020 Activation of Neurogenesis in Multipotent Stem Cells Cultured In Vitro and in the Spinal Cord Tissue After Severe Injury by Inhibition of Glycogen Synthase Kinase-3 Neurotherapeutics 18 515 533 | |
dc.identifier.uri | https://hdl.handle.net/10550/82709 | |
dc.description.abstract | The inhibition of glycogen synthase kinase-3 (GSK-3) can induce neurogenesis, and the associated activation of Wnt/β-catenin signaling via GSK-3 inhibition may represent a means to promote motor function recovery following spinal cord injury (SCI) via increased astrocyte migration, reduced astrocyte apoptosis, and enhanced axonal growth. Herein, we assessed the effects of GSK-3 inhibition in vitro on the neurogenesis of ependymal stem/progenitor cells (epSPCs) resident in the mouse spinal cord and of human embryonic stem cell-derived neural progenitors (hESC-NPs) and human-induced pluripotent stem cell-derived neural progenitors (hiPSC-NPs) and in vivo on spinal cord tissue regeneration and motor activity after SCI. We report that the treatment of epSPCs and human pluripotent stem cell-derived neural progenitors (hPSC-NPs) with the GSK-3 inhibitor Ro3303544 activates β-catenin signaling and increases the expression of the bIII-tubulin neuronal marker; furthermore, the differentiation of Ro3303544-treated cells prompted an increase in the number of terminally differentiated neurons. Administration of a water-soluble, bioavailable form of this GSK-3 inhibitor (Ro3303544-Cl) in a severe SCI mouse model revealed the increased expression of bIII-tubulin in the injury epicenter. Treatment with Ro3303544-Cl increased survival of mature neuron types from the propriospinal tract (vGlut1, Parv) and raphe tract (5-HT), protein kinase C gamma-positive neurons, and GABAergic interneurons (GAD65/67) above the injury epicenter. Moreover, we observed higher numbers of newly born BrdU/DCX-positive neurons in Ro3303544-Cl-treated animal tissues, a reduced area delimited by astrocyte scar borders, and improved motor function. Based on this study, we believe that treating animals with epSPCs or hPSC-NPs in combination with Ro3303544-Cl deserves further investigation towards the development of a possible therapeutic strategy for SCI. | |
dc.language.iso | eng | |
dc.relation.ispartof | Neurotherapeutics, 2020, vol. 18, p. 515-533 | |
dc.subject | Cèl·lules mare | |
dc.subject | Neurones | |
dc.subject | Neurologia | |
dc.title | Activation of Neurogenesis in Multipotent Stem Cells Cultured In Vitro and in the Spinal Cord Tissue After Severe Injury by Inhibition of Glycogen Synthase Kinase-3 | |
dc.type | journal article | es_ES |
dc.date.updated | 2022-05-10T14:30:32Z | |
dc.identifier.doi | 10.1007/s13311-020-00928-0 | |
dc.identifier.idgrec | 152646 | |
dc.rights.accessRights | open access | es_ES |